Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Apyx Medical Corp Director's Dealing 2011

Dec 2, 2011

34303_dirs_2011-12-02_8e326dc7-f071-4dee-bbd1-ecf020e488a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOVIE MEDICAL CORP (bvx)
CIK: 0000719135
Period of Report: 2011-11-29

Reporting Person: CITRONOWICZ MOSHE (Director of Strategic Developm)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-29 Stock option $3.25 J 25000 Disposed 2013-09-29 Common stock (25000) Direct
2011-11-29 Stock option $2.13 J 25000 Disposed 2014-09-23 Common stock (25000) Direct
2011-11-29 Stock options $2.25 J 25000 Disposed 2015-05-05 Common stock (25000) Direct

Footnotes

F1: a total of 75,000 stock options related to various grant dates were surrendered pursuant to an agreement.